the risk of jaw bone damage while taking Fosamax or other bisphosphonates

August 2006

Lots of worried patients are asking about the risk of jaw bone damage while taking Fosamax or other bisphosphonates.

Questions about osteonecrosis of the jaw have really picked up since we alerted you to this rare problem last year.

The incidence is very low for patients taking ORAL Fosamax, Actonel, or Boniva for osteoporosis. It's probably less than 1 case per 100,000 patients per year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

the risk of jaw bone damage while taking Fosamax or other bisphosphonates
Cardiology Zocor and the new generic simvastatins
Cardiology guidelines to help determine which patients should be STARTED on beta-blockers before non-cardiac surgery
Vaccines CDC will soon recommend a booster of the chickenpox vaccine
Vaccines shortage of Menactra (meningococcal vaccine)
Neurology & Pain two new ORAL forms of oxymorphone called Opana and Opana ER
Diabetes New "guidelines" for treating pain due to diabetic peripheral neuropathy
Infectious Diseases several changes in HIV drug therapy
Women's Health new oral contraceptive called Seasonique
Women's Health prenatal vitamins with DHA
treatment options for eating disorders
Hematology & Oncology Sprycel (dasatinib), a new oral drug for certain forms of leukemia
Hematology & Oncology Cesamet (nabilone) is a new option for nausea and vomiting associated with chemotherapy
Smoking Cessation Chantix (varenicline) is the latest option for smoking cessation

the risk of jaw bone damage while taking Fosamax or other bisphosphonates

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents